XBIT XBiotech Inc. - Common Stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 13, 2026
$2,19
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$2,0952-Wochen-Tief
$3,4452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$67M
P/E
-1.6
EPS
$-1.49
Umsatz
$0
Ihre Abzeichen
52W-Spanne
$2–$3
Analystenbewertung
BUY
Kursziel
·
P/E
-1.6
ROE
·
Nettogewinnmarge
·
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
XBIT Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.19
Marktkapitalisierung (MRQ)
$67M
P/E
-1.6
EPS
$-1.49
Umsatz
$0
52W-Spanne
$2–$3
XBIT Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$02018-12-31 → 2023-12-31
EPS$-1.492017-12-31 → 2025-12-31
Freier Cashflow·2016-12-31 → 2022-12-31
Nettogewinnmarge·2020-12-31 → 2022-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | XBIT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E | -1.65-Jahres-Durchschnitt ≈-6.4 | ≈-6.4 | · | · | |
| K/B (MRQ) | 0.5 | · | 1.7 | Unterbewertet | |
| Kurs / FCF (TTM) | -1.6 | · | · | · | |
| Kurs / Cashflow (TTM) | -1.6 | · | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.55-Jahres-Durchschnitt ≈0.7 | ≈0.7 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | XBIT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 33.2 | · | 5.2 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | XBIT | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$0.00 | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Jul 15, 2021 | $2,50 | USD | ≈15.1% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
2383.3%
Nächster Bericht
Nov 10, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 31. März 2020 | $0.00 | $0.06 | -100.0% | |
| 31. Dezember 2019 | $14.59 | $-0.15 | 9635.9% | |
| 30. September 2019 | $-0.15 | $-0.15 | 2.0% | |
| 30. Juni 2019 | $-0.16 | $-0.15 | -4.6% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $4M | $18M | $44M | $0 | $0 | |
| Cost of Revenue | · | · | $0 | $651.0K | $6M | $35M | $0 | $0 | |
| Gross Profit | · | · | $0 | $3M | $13M | $9M | $0 | $0 | |
| R&D Expense | $47M | $38M | $33M | $32M | $28M | $10M | $24M | $16M | |
| SG&A Expense | $8M | $5M | $5M | $6M | $9M | $18M | $7M | $5M | |
| Operating Expenses | · | $42M | $38M | $38M | $38M | $28M | $31M | $21M | |
| Operating Income | $-56M | $-42M | $-38M | $-34M | $-25M | $-18M | $-31M | $-21M | |
| Other Non-op | $1M | $432.0K | $883.0K | $-121.0K | $-132.0K | $-503.0K | $10.0K | $4.0K | |
| Pretax Income | $-45M | $-39M | $-24M | $-34M | $-25M | $-13M | $718M | $-21M | |
| Income Tax | $235.0K | $-32.0K | $244.0K | $-688.0K | $-8M | $-2M | $50M | $0 | |
| Net Income | $-46M | $-39M | $-25M | $-33M | $-17M | $-11M | $669M | $-21M | |
| EPS (Basic) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $17.17 | $-0.59 | |
| EPS (Diluted) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $14.44 | $-0.59 | |
| Shares (Basic) | 30,487,731 | 30,460,980 | 30,438,459 | 30,439,275 | 30,043,380 | 30,823,458 | 38,945,468 | 35,804,304 | |
| Shares (Diluted) | 30,487,731 | 30,460,980 | 30,438,459 | 30,439,275 | 30,043,380 | 30,823,458 | 46,319,457 | 35,804,304 | |
| EBITDA | · | · | · | $-34M | $-25M | $-18M | $-31M | $-21M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $126M | $173M | $200M | $157M | $237M | $237M | $715M | $16M | |
| Short-term Investments | · | · | $0 | $60M | $0 | · | · | · | |
| Receivables | · | $700.0K | $860.0K | $1M | $0 | $4M | $0 | · | |
| Prepaid Expense | $1M | $1M | $760.0K | $601.0K | $934.0K | $582.0K | $2M | $1M | |
| Current Assets | $127M | $175M | $202M | $220M | $247M | $326M | $716M | $17M | |
| PP&E (Net) | $23M | $25M | $25M | $26M | $28M | $27M | $25M | $27M | |
| Accum. Depreciation | · | $22M | $20M | $16M | $16M | $13M | $12M | $9M | |
| Total Assets | $150M | $199M | $227M | $246M | $275M | $354M | $817M | $44M | |
| Accounts Payable | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | |
| Accrued Liabilities | $6M | $3M | $4M | $2M | $1M | $1M | $4M | $1M | |
| Current Liabilities | $8M | $15M | $6M | $4M | $3M | $4M | $60M | $3M | |
| Deferred Tax | $5.0K | $0 | $0 | $59.0K | $873.0K | $0 | · | · | |
| Total Liabilities | $10M | $17M | $8M | $6M | $6M | $5M | $61M | $3M | |
| Common Stock | $277M | $273M | $271M | $267M | $262M | $250M | $325M | $279M | |
| Retained Earnings | $-136M | $-91M | $-52M | $-28M | $5M | $98M | $431M | $-238M | |
| AOCI | · | · | $0 | $826.0K | $2M | $1M | $-106.0K | $-255.0K | |
| Stockholders' Equity | $140M | $182M | $219M | $240M | $269M | $349M | $756M | $41M | |
| Liabilities + Equity | $150M | $199M | $227M | $246M | $275M | $354M | $817M | $44M | |
| Shares Outstanding | 30,487,731 | 30,487,731 | 30,436,964 | 30,439,275 | 30,439,275 | 29,304,396 | 41,519,633 | 35,899,772 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $4M | $2M | $3M | $5M | $4M | $13M | $3M | $2M | |
| Deferred Tax | $5.0K | $0 | $-59.0K | $-816.0K | $1M | $-47.0K | $-13.0K | $0 | |
| Operating Cash Flow | $-40M | $-31M | $-19M | $-15M | $69M | $-65M | $-18M | $-17M | |
| CapEx | $289.0K | $1M | $362.0K | $585.0K | $4M | $4M | $204.0K | $122.0K | |
| Investing Cash Flow | $-289.0K | $-1M | $61M | $-64M | $-4M | $-4M | $675M | $-122.0K | |
| Stock Issued | · | · | $4.8K | · | $8M | $10M | $4M | · | |
| Stock Repurchased | · | $0 | $14.0K | $0 | · | · | · | · | |
| Net Stock Activity | · | · | · | · | $8M | $10M | $4M | · | |
| Dividends Paid | · | · | · | $0 | $75M | $0 | $0 | · | |
| Financing Cash Flow | $-10M | $10M | $-9.0K | $0 | $-67M | $-410M | $42M | $201.0K | |
| Net Change in Cash | $-47M | $-27M | $43M | $-80M | $-383.0K | $-477M | $699M | $-16M | |
| Taxes Paid | $-81.0K | $87.0K | $141.0K | · | · | · | · | · | |
| Free Cash Flow | · | · | · | $-15M | $66M | $-69M | $-18M | $-17M |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | 83.8% | 68.4% | 21.5% | · | · | |
| Operating Margin | · | · | · | -860.1% | -136.4% | -41.5% | · | · | |
| Net Margin | · | · | · | -820.4% | -94.7% | -25.5% | · | · | |
| Pretax Margin | · | · | · | -837.6% | -138.4% | -29.1% | · | · | |
| EBITDA Margin | · | · | · | -860.1% | -136.4% | -41.5% | · | · | |
| ROA | · | · | · | -12.6% | -5.5% | -1.9% | 155.3% | -39.4% | |
| ROE | · | · | · | -13.6% | -6.4% | -3.2% | 163.0% | -47.9% | |
| ROIC | · | · | · | -14.1% | -6.4% | -4.6% | -3.9% | -50.7% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 54.1 | 71.5 | 81.8 | 11.9 | 5.8 | |
| Quick Ratio | · | · | · | 53.5 | 68.6 | 60.6 | 11.9 | 5.4 |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.1 | 0.1 | · | · | |
| Receivables Turnover | · | · | · | · | 8.9 | 21.4 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | $7.90 | $8.85 | $11.90 | $18.20 | $1.15 | |
| Revenue / Share | · | · | · | $0.13 | $0.61 | $1.43 | · | · | |
| Cash Flow / Share | · | · | · | $-0.49 | $2.31 | $-2.11 | $-0.39 | · | |
| Cash / Share | · | · | · | $5.17 | $7.79 | $8.10 | $17.21 | $0.44 | |
| EPS (TTM) | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 | $-0.36 | $14.44 | $-0.59 |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | · | -78.2% | -58.2% | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $2M | $0 | $4M | $18M | $44M | $0 | $0 | |
| Net Income TTM | $-46M | $-39M | $-25M | $-33M | $-17M | $-11M | $669M | $-21M | |
| Market Cap | · | · | · | $107M | $339M | $459M | $775M | $182M | |
| P/E | -1.6 | -3.1 | -4.9 | -3.2 | -19.2 | -43.5 | 1.3 | -8.6 | |
| P/S | · | · | · | 26.6 | 18.4 | 10.4 | · | · | |
| P/B | · | · | · | 0.4 | 1.3 | 1.3 | 1.0 | 4.4 | |
| P / Tangible Book | 0.5 | 0.7 | 0.6 | 0.4 | 1.3 | 1.3 | · | · | |
| P / Cash Flow | · | · | · | -7.2 | 4.9 | -7.0 | -42.4 | -11.0 | |
| P / FCF | · | · | · | -6.9 | 5.1 | -6.7 | -41.9 | -10.9 | |
| Dividend Yield | · | · | · | 0.00% | 22.1% | 0.00% | 0.00% | · | |
| Earnings Yield | -62.3% | -31.9% | -20.2% | -30.8% | -5.2% | -2.3% | 77.4% | -11.6% | |
| Payout Ratio | · | · | · | 0.00% | -430.7% | · | · | · | |
| Annual Payout | · | · | · | $0 | $75M | $0 | $0 | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $300.0K | $2M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $16.0K | $215.0K | |
| Gross Profit | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $284.0K | $1M | |
| R&D Expense | $5M | $5M | $25M | $5M | $5M | $12M | $8M | $7M | $13M | $10M | $8M | $8M | $11M | $6M | $7M | $7M | |
| SG&A Expense | $850.0K | $1M | $4M | $967.0K | $1M | $2M | $927.0K | $777.0K | $2M | $1M | $782.0K | $973.0K | $2M | $915.0K | $1M | $840.0K | |
| Operating Expenses | $6M | · | · | $6M | $6M | $14M | $9M | $8M | $15M | $11M | $9M | $9M | $13M | $7M | $8M | $8M | |
| Operating Income | $-6M | $-6M | $-30M | $-6M | $-6M | $-14M | $-9M | $-8M | $-15M | $-11M | $-9M | $-9M | $-13M | $-7M | $-8M | $-6M | |
| Other Non-op | $-9.0K | $1M | $549.0K | $-85.0K | $-3.0K | $995.0K | $407.0K | $25.0K | $0 | $0 | $3.0K | $0 | $750.0K | $130.0K | $-2.0K | $0 | |
| Pretax Income | $-7M | $-5M | $-27M | $-6M | $-2M | $-11M | $-11M | $-5M | $-13M | $-10M | $-5M | $-7M | $-9M | $-4M | $-3M | $-10M | |
| Income Tax | $46.0K | $49.0K | $76.0K | $102.0K | $28.0K | $29.0K | $-41.0K | $9.0K | $-25.0K | $25.0K | $-172.0K | $308.0K | $71.0K | $37.0K | $578.0K | $2M | |
| Net Income | $-7M | $-6M | $-27M | $-6M | $-2M | $-11M | $-11M | $-5M | $-13M | $-10M | $-5M | $-7M | $-9M | $-4M | $-3M | $-13M | |
| EPS (Basic) | $-0.22 | $-0.18 | $-0.87 | $-0.20 | $-0.06 | $-0.36 | $-0.34 | $-0.16 | $-0.43 | $-0.33 | $-0.15 | $-0.24 | $-0.29 | $-0.13 | $-0.10 | $-0.42 | |
| Shares (Basic) | 30,487,731 | 30,487,731 | · | 30,487,731 | 30,487,731 | 30,487,731 | · | 30,472,557 | 30,456,101 | 30,443,973 | · | 30,436,638 | 30,439,118 | 30,439,275 | · | 30,439,277 | |
| EBITDA | $-6M | $-6M | · | $-6M | $-6M | $-14M | · | $-8M | $-15M | $-11M | · | $-9M | $-13M | $-7M | · | $-6M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $110M | $115M | $126M | $147M | $153M | $156M | $173M | $183M | $189M | $201M | $200M | $202M | $143M | $152M | $157M | $161M | |
| Short-term Investments | · | · | · | · | · | · | · | · | · | · | · | $0 | $61M | $60M | $60M | $60M | |
| Receivables | · | · | · | $450.0K | $480.0K | $480.0K | · | $730.0K | $870.0K | $870.0K | · | $881.0K | · | · | · | $2M | |
| Prepaid Expense | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $760.0K | $879.0K | $947.0K | $703.0K | $601.0K | $621.0K | |
| Current Assets | $111M | $117M | $127M | $149M | $155M | $158M | $175M | $185M | $191M | $203M | $202M | $204M | $210M | $216M | $220M | $223M | |
| PP&E (Net) | $22M | $23M | $23M | $23M | $24M | $24M | $25M | $25M | $25M | $25M | $25M | $25M | $26M | $26M | $26M | $27M | |
| Accum. Depreciation | · | · | · | · | · | · | $22M | · | · | · | $18M | · | · | · | $16M | · | |
| Total Assets | $134M | $140M | $150M | $172M | $179M | $182M | $199M | $210M | $216M | $228M | $227M | $230M | $235M | $242M | $246M | $251M | |
| Accounts Payable | $1M | $857.0K | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $1M | $2M | $1M | $2M | $1M | |
| Accrued Liabilities | $2M | $2M | $6M | $2M | $2M | $4M | $3M | $4M | $5M | $4M | $4M | $4M | $3M | $2M | $2M | $2M | |
| Current Liabilities | $3M | $3M | $8M | $4M | $4M | $5M | $15M | $16M | $17M | $17M | $6M | $5M | $4M | $4M | $4M | $4M | |
| Deferred Tax | $5.0K | $5.0K | $5.0K | · | · | · | $0 | · | · | · | · | $0 | $0 | $0 | $59.0K | $872.0K | |
| Total Liabilities | $5M | $5M | $10M | $5M | $6M | $7M | $17M | $18M | $19M | $19M | $8M | $7M | $6M | $5M | $6M | $6M | |
| Common Stock | $277M | $277M | $277M | $277M | $277M | $276M | $273M | $272M | $272M | $272M | $271M | $270M | $269M | $268M | $267M | $266M | |
| Retained Earnings | $-149M | $-142M | $-136M | $-109M | $-103M | $-102M | $-91M | $-80M | $-75M | $-62M | $-52M | $-48M | $-40M | $-32M | $-28M | $-25M | |
| AOCI | · | · | · | · | · | · | · | · | · | · | · | $440.0K | $440.0K | $440.0K | $826.0K | $3M | |
| Stockholders' Equity | $128M | $135M | $140M | $167M | $173M | $175M | $182M | $192M | $197M | $209M | $219M | $223M | $229M | $237M | $240M | $245M | |
| Liabilities + Equity | $134M | $140M | $150M | $172M | $179M | $182M | $199M | $210M | $216M | $228M | $227M | $230M | $235M | $242M | $246M | $251M | |
| Shares Outstanding | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,487,731 | 30,479,406 | 30,463,156 | 30,450,881 | 30,436,964 | 30,436,964 | 30,435,714 | 30,439,275 | 30,439,275 | 30,439,277 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $172.0K | $172.0K | $162.0K | $24.0K | $107.0K | $3M | $628.0K | $365.0K | $379.0K | $381.0K | $688.0K | $955.0K | $914.0K | $705.0K | $1M | $1M | |
| Operating Cash Flow | $-5M | $-9M | $-23M | $-4M | $-6M | $-7M | $-7M | $-6M | $-11M | $-7M | $-3M | $-1M | $-9M | $-5M | $-3M | $-160.0K | |
| CapEx | $0 | $0 | $34.0K | $110.0K | $51.0K | $94.0K | $84.0K | $338.0K | $627.0K | $255.0K | $115.0K | $33.0K | $208.0K | $6.0K | $132.0K | $210.0K | |
| Investing Cash Flow | $-4.0K | $9.0K | $-34.0K | $-110.0K | $-51.0K | $-94.0K | $-84.0K | $-338.0K | $-627.0K | $-255.0K | $-115.0K | $62M | $-208.0K | $-6.0K | $-4M | $-60M | |
| Stock Issued | · | · | · | · | · | · | · | $64.0K | $48.0K | $55.0K | · | · | · | · | · | · | |
| Stock Repurchased | · | · | · | · | · | · | · | $0 | · | · | $0 | $0 | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $55.0K | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | $0 | $0 | $0 | $0 | $-10M | $283.0K | $64.0K | $48.0K | $10M | $0 | $5.0K | $-14.0K | $0 | $0 | $0 | |
| Net Change in Cash | $-6M | $-10M | $-22M | $-6M | $-3M | $-17M | $-10M | $-5M | $-13M | $1M | $-2M | $59M | $-9M | $-5M | $-3M | $-65M | |
| Free Cash Flow | · | $-9M | · | · | · | $-7M | · | · | · | $-7M | · | · | · | $-5M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 87.2% | |
| Operating Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -380.3% | |
| Net Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -753.5% | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -610.5% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | -380.3% | |
| ROA | -4.3% | -3.4% | · | -3.1% | -0.89% | -5.3% | · | -2.3% | -5.8% | -4.3% | · | -3.1% | -3.5% | -1.5% | · | -4.8% | |
| ROE | -4.5% | -3.5% | · | -3.4% | -0.95% | -5.7% | · | -2.4% | -6.1% | -4.5% | · | -3.1% | -3.6% | -1.5% | · | -4.9% | |
| ROIC | -4.8% | -4.7% | · | -3.7% | -3.7% | -7.8% | · | -4.1% | -7.6% | -5.2% | · | -4.0% | -5.8% | -3.0% | · | -3.2% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 33.2 | 39.0 | · | 41.8 | 40.2 | 29.1 | · | 11.6 | 11.1 | 12.0 | · | 38.6 | 47.1 | 59.8 | · | 62.4 | |
| Quick Ratio | 32.7 | 38.5 | · | 41.5 | 39.8 | 28.9 | · | 11.5 | 11.1 | 12.0 | · | 38.4 | 46.0 | 58.8 | · | 61.9 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | · | 0.0 | · | · | · | 2.1 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.21 | $4.43 | · | $5.48 | $5.68 | $5.73 | · | $6.30 | $6.46 | $6.87 | · | $7.32 | $7.53 | $7.78 | · | $8.04 | |
| Cash / Share | $3.59 | $3.79 | · | $4.83 | $5.02 | $5.11 | · | $6.01 | $6.19 | $6.60 | · | $6.64 | $4.71 | $5.01 | · | $5.28 | |
| EPS (TTM) | $14.35 | $14.35 | · | $14.35 | $14.35 | $14.35 | · | $14.35 | $14.35 | $14.35 | · | $14.35 | $14.35 | $14.35 | · | $14.35 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $300.0K | $300.0K | · | $300.0K | $300.0K | $300.0K | · | $300.0K | $300.0K | $300.0K | · | $300.0K | $2M | $4M | · | $8M | |
| Net Income TTM | $-45M | $-40M | · | $-29M | $-28M | $-39M | · | $-33M | $-35M | $-31M | · | $-23M | $-28M | $-31M | · | $-36M | |
| Market Cap | $70M | $72M | · | $81M | $91M | $99M | · | $236M | $157M | $248M | · | $125M | $181M | $105M | · | $110M | |
| P/E | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.5 | 0.4 | 0.6 | · | 0.3 | 0.4 | 0.2 | · | 0.3 | |
| P/S | 233.7 | 238.8 | · | 270.3 | 301.8 | 329.3 | · | 785.4 | 521.9 | 825.2 | · | 418.0 | 91.3 | 29.9 | · | 13.4 | |
| P/B | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 1.2 | 0.8 | 1.2 | · | 0.6 | 0.8 | 0.4 | · | 0.5 | |
| P / Tangible Book | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 1.2 | 0.8 | 1.2 | · | 0.6 | 0.8 | 0.4 | · | 0.5 | |
| P / Cash Flow | · | -8.0 | · | · | · | -14.7 | · | · | · | -34.4 | · | · | · | -21.8 | · | · | |
| Earnings Yield | 623.9% | 610.6% | · | 539.5% | 483.2% | 442.9% | · | 185.6% | 279.2% | 176.5% | · | 348.3% | 241.6% | 415.9% | · | 396.4% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | · | · | $0 | $4M | $18M |
| Bruttogewinnmarge % | · | · | · | 83.8% | 68.4% |
| Betriebsgewinnmarge % | · | · | · | -860.1% | -136.4% |
| Nettoergebnis | $-46M | $-39M | $-25M | $-33M | $-17M |
| Verwässerte EPS | $-1.49 | $-1.26 | $-0.81 | $-1.08 | $-0.58 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | · | · | · | 54.1 | 71.5 |
| Quick Ratio | · | · | · | 53.5 | 68.6 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | · | · | · | $-15M | $66M |
Institutionelle Eigentümer (13F) 46 Einreicher · $5.6M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
46
Gehaltener Wert
$5.6M
Neue Positionen
5
Geschlossene Positionen
3
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 5 (-2 vs. Vorquartal) | 3 (-5 vs. Vorquartal) | 6 (-2 vs. Vorquartal) | 12 (0 vs. Vorquartal) | +116K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $738.636 | 321.146 | 13,08% | Aktien |
| VANGUARD GROUP INC | $715.940 | 299.556 | 12,67% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $492.755 | 214.116 | 8,72% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $460.419 | 200.182 | 8,15% | Aktien |
| RBF Capital, LLC | $456.552 | 198.501 | 8,08% | Aktien |
| MORGAN STANLEY | $340.124 | 147.880 | 6,02% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $226.428 | 98.447 | 4,01% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $212.440 | 92.365 | 3,76% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $182.459 | 79.330 | 3,23% | Aktien |
| JANE STREET GROUP, LLC | $171.810 | 74.700 | 3,04% | Kaufoption |
| STATE STREET CORP | $167.914 | 73.006 | 2,97% | Aktien |
| NORTHERN TRUST CORP | $152.394 | 66.258 | 2,70% | Aktien |
| Empowered Funds, LLC | $136.958 | 59.547 | 2,42% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $101.200 | 44.000 | 1,79% | Verkaufsoption |
| RENAISSANCE TECHNOLOGIES LLC | $95.825 | 41.663 | 1,70% | Aktien |
| Bank of New York Mellon Corp | $90.517 | 39.355 | 1,60% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $82.990 | 36.053 | 1,47% | Aktien |
| Squarepoint Ops LLC | $79.941 | 34.757 | 1,42% | Aktien |
| Qube Research & Technologies Ltd | $77.211 | 33.570 | 1,37% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $68.770 | 29.900 | 1,22% | Kaufoption |
| CITADEL ADVISORS LLC | $67.142 | 29.192 | 1,19% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $64.269 | 27.943 | 1,14% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $60.867 | 26.464 | 1,08% | Aktien |
| NATIONAL BANK OF CANADA /FI/ | $57.500 | 25.000 | 1,02% | Aktien |
| BANK OF AMERICA CORP /DE/ | $54.715 | 23.789 | 0,97% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $42.276 | 18.381 | 0,75% | Aktien |
| TWO SIGMA ADVISERS, LP | $38.957 | 16.300 | 0,69% | Aktien |
| SYNOVUS FINANCIAL CORP | $31.377 | 11.796 | 0,56% | Aktien |
| Thomasville National Bank | $30.705 | 13.350 | 0,54% | Aktien |
| XTX Topco Ltd | $30.084 | 13.080 | 0,53% | Aktien |
| Pinnacle Financial Partners, Inc. | $27.131 | 11.796 | 0,48% | Aktien |
| JANE STREET GROUP, LLC | $26.394 | 11.476 | 0,47% | Aktien |
| Point72 Asia (Singapore) Pte. Ltd. | $18.133 | 6.817 | 0,32% | Aktien |
| Vanguard Global Advisers, LLC | $16.121 | 7.009 | 0,29% | Aktien |
| Cubist Systematic Strategies, LLC | $14.151 | 5.320 | 0,25% | Aktien |
| UBS Group AG | $11.581 | 5.035 | 0,21% | Aktien |
| ROYAL BANK OF CANADA | $3.000 | 1.206 | 0,05% | Aktien |
| McIlrath & Eck, LLC | $1.770 | 753 | 0,03% | Aktien |
| JONES FINANCIAL COMPANIES LLLP | $862 | 370 | 0,02% | Aktien |
| JPMORGAN CHASE & CO | $224 | 96 | 0,00% | Aktien |
| BARCLAYS PLC | $216 | 94 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $85 | 37 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $71 | 30.654 | 0,00% | Aktien |
| Larson Financial Group LLC | $48 | 21 | 0,00% | Aktien |
| CWM, LLC | $31 | 13 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $25 | 11 | 0,00% | Aktien |
Unternehmensinsider 23 Insider · 10 Führungskräfte · 11 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| John Simard | Chief Executive Officer | 17. März 2025 A | 3.823.166 | 0 | 0 | $0 |
| James Scott Whitehurst | Chief Financial Officer | 2. Mai 2016 A | · | 0 | 0 | $0 |
| Sushma Shivaswamy | Chief Scientific Officer | 10. Februar 2023 A | 0 | 0 | 0 | $0 |
| Queena Han | VP Finance & HR | 19. November 2021 A | 57.692 | 0 | 0 | $0 |
| Benjamin Guzman | Sr.VP Corp. Strategy & Finance | 7. Juli 2017 A | · | 0 | 0 | $0 |
| Michael Stecher | Medical Director | 19. Juni 2017 M | 0 | 0 | 0 | $0 |
| Trey Benson | VP of Commercial Development | 20. Juni 2016 A | · | 0 | 0 | $0 |
| Dawn Mccollough | VP Clinical Operations | 16. Mai 2016 A | · | 0 | 0 | $0 |
| Kalidip Choudhury | VP of Business Development | 14. Dezember 2015 M | · | 0 | 0 | $0 |
| Kelly Thornburg | SVP of Operations | 8. Juni 2015 A | · | 0 | 0 | $0 |
| David Spencer Soffer | Direktor | 1. Oktober 2025 A | · | 0 | 0 | $0 |
| Thomas Martin Kuendig | Direktor | 1. Oktober 2025 A | · | 0 | 0 | $0 |
| Tevi David Troy | Direktor | 1. Oktober 2025 A | · | 0 | 0 | $0 |
| Craig Evan Rademaker | Direktor | 1. Oktober 2025 A | · | 0 | 0 | $0 |
| Peter Libby | Direktor | 20. Juni 2024 A | · | 0 | 0 | $0 |
| Donald H. Macadam | Direktor | 20. Juni 2024 A | 10.000 | 0 | 0 | $0 |
| Jan-Paul Waldin | Direktor | 20. Juni 2024 A | 200.243 | 0 | 0 | $0 |
| Thorpe W Mckenzie | Direktor | 20. Juni 2024 A | 2.597.471 | 0 | 0 | $0 |
| Daniel Vasella | Direktor | 19. Juni 2017 M | · | 0 | 0 | $0 |
| Fabrizio Bonanni | Direktor | 19. Juni 2017 M | · | 0 | 0 | $0 |
| BAY STREET FINANCIAL S.A. | 10%-Eigentümer | 18. Dezember 2020 S | 1.981.515 | 0 | 0 | $0 |
| Thomas Gut | 10%-Eigentümer | 12. Februar 2020 D | 3.914.111 | 0 | 0 | $0 |
| Fondation Rennes | 10%-Eigentümer | 3. Februar 2020 G | 110.282 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 2 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
XBIT Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 7 Analysten
KAUF
2 28,6%
Starker Kauf
4 57,1%
Kauf
1 14,3%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| XBIT | · | -1.6 | · | · | · | · |
| ALDX | $312M | -9.2 | · | · | -68.0% | · |
| GRML | · | · | · | · | -104.9% | · |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | · |
| RNTX | · | -0.6 | · | · | · | · |
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| APLM | · | -2.5 | · | -128.7% | -1305.4% | · |
| FBIO | · | · | · | · | · | · |
| NMAD | · | · | · | · | · | · |
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 13, 2026